Add time:08/19/2019 Source:sciencedirect.com
Objectives.Our primary objective was to compare the effects of three different doses of candoxatrilat (cas 123898-42-0) with the effects of placebo on urinary volume in patients with moderately severe heart failure. The effects of candoxatrilat on urinary composition, neuroendocrine indexes and renal hemodynamic function were also studied.
We also recommend Trading Suppliers and Manufacturers of candoxatrilat (cas 123898-42-0). Pls Click Website Link as below: cas 123898-42-0 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View